Search

Your search keyword '"Ronald L. Hamilton"' showing total 174 results

Search Constraints

Start Over You searched for: Author "Ronald L. Hamilton" Remove constraint Author: "Ronald L. Hamilton" Search Limiters Full Text Remove constraint Search Limiters: Full Text
174 results on '"Ronald L. Hamilton"'

Search Results

1. The transcriptional landscape of Shh medulloblastoma

2. Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma

3. Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load

4. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex

5. EphA2 as a Glioma-Associated Antigen: A Novel Target for Glioma Vaccines

6. Supplementary Tables 1-15 from Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer

7. Supplementary Figures 1-7 from Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast Cancer

9. Supplementary Table 2 from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

10. Supplementary Figures from Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients

11. Supplementary Table 1 from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

12. Data from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

15. Supplementary Figure 1 from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

16. Supplementary Figure 2 from Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

17. Data from Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients

18. Data from LOH in the HLA Class I Region at 6p21 Is Associated with Shorter Survival in Newly Diagnosed Adult Glioblastoma

25. Data from COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells

26. New insights into the genetic etiology of Alzheimer's disease and related dementias

27. Clinical Utility of GlioSeq Next-Generation Sequencing Test in Pediatric and Young Adult Patients With Brain Tumors

28. Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases

29. BIFoR FACE: Water-soil-vegetation-atmosphere research in a temperate deciduous forest catchment, including under elevated CO2

30. Pattern of Relapse and Treatment Response in WNT- Activated Medulloblastoma

31. GABA bouton subpopulations in the human dentate gyrus are differentially altered in mesial temporal lobe epilepsy

32. Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load

33. Abstract PD1-05: Breast cancer brain metastases show limited intrinsic subtype switching, yet exhibit acquired ERBB2 amplifications and activating mutations

34. Identification of recurrent fusion genes across multiple cancer types

35. Pattern of Relapse and Treatment Response in WNT-Activated Medulloblastoma

36. Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study

37. Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study

38. Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors

39. Identification of Novel RAS Signaling Therapeutic Vulnerabilities in Diffuse Intrinsic Pontine Gliomas

40. RARE-18. OSTEOSARCOMA AND MEDULLOBLASTOMA IN A LI-FRAUMENI PATIENT

41. Frequent ESR1 and CDK Pathway Copy Number Alterations in Metastatic Breast Cancer

42. Subacute histopathological features in a case of varicella zoster virus myelitis and post-herpetic neuralgia

43. Expression of high affinity folate receptor in breast cancer brain metastasis

44. Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC

45. Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets

46. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

47. Intertumoral Heterogeneity within Medulloblastoma Subgroups

48. Hyperphosphorylated Tau is Elevated in Alzheimer's Disease with Psychosis

49. First use of 18 F‐labeled ML‐10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy

50. Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases

Catalog

Books, media, physical & digital resources